{"meta":{"query_hash":"4c4dfa6dda92","filters":{"venue":"Global Cardiology"},"cohort_total":8,"direct_labels_cover":0,"predictions_cover":8,"exported":8,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/4c4dfa6dda92","api":"https://metacan.xera.ac/api/v1/cohort?venue=Global+Cardiology"},"results":[{"id":"W4390758410","doi":"10.4081/globcardio.2023.2","title":"SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials","year":2023,"lang":"en","type":"article","venue":"Global Cardiology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Empagliflozin; Dapagliflozin; Medicine; Hazard ratio; Internal medicine; Placebo; Randomized controlled trial; Meta-analysis; Confidence interval; Diabetes mellitus; Relative risk; Type 2 diabetes; Endocrinology","score_opus":0.044553951690806344,"score_gpt":0.33098623453234705,"score_spread":0.2864322828415407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390758410","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019606743,0.9756766,0.0018714728,0.0004596069,0.00045342735,0.0005493283,0.00080343144,0.0000836037,0.00049580395],"genre_scores_gemma":[0.52715296,0.46003985,0.0053610657,0.0018551596,0.000997402,0.0021711385,0.0017557006,0.000100156496,0.00056654325],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98241377,0.011062135,0.0032278015,0.0015726887,0.0012937984,0.0004298938],"domain_scores_gemma":[0.968702,0.024018282,0.004493068,0.0012425141,0.0011652397,0.00037880518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024050888,0.0030940836,0.020160362,0.0043691057,0.00049809174,0.0032704696,0.0019611062,0.0019817161,0.003926716],"category_scores_gemma":[0.036009878,0.0013485813,0.04999937,0.0051131207,0.0006555039,0.0016466225,0.0011789488,0.0025973655,0.00031965127],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01139208,0.0000423908,0.0037139992,0.060614273,0.9164058,0.00005734359,0.000024309024,0.0006458803,0.000110211935,0.00007392007,0.00036154405,0.0065583405],"study_design_scores_gemma":[0.0038103887,0.00035865154,0.003091056,0.0038545583,0.98761857,0.00004221001,0.000014989637,0.00033856687,0.00006480753,0.0002346004,0.00055530015,0.000016288379],"about_ca_topic_score_codex":0.0025670754,"about_ca_topic_score_gemma":0.004332039,"teacher_disagreement_score":0.024050888,"about_ca_system_score_codex":0.001700686,"about_ca_system_score_gemma":0.0018585471,"threshold_uncertainty_score":0.12719476},"labels":[],"label_agreement":null},{"id":"W4390776745","doi":"10.4081/globalcard.2023.2","title":"SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials","year":2023,"lang":"en","type":"article","venue":"Global Cardiology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Empagliflozin; Dapagliflozin; Medicine; Hazard ratio; Internal medicine; Placebo; Randomized controlled trial; Meta-analysis; Relative risk; Diabetes mellitus; Confidence interval; Type 2 diabetes; Endocrinology","score_opus":0.044553951690806344,"score_gpt":0.33098623453234705,"score_spread":0.2864322828415407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390776745","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019606743,0.9756766,0.0018714728,0.0004596069,0.00045342735,0.0005493283,0.00080343144,0.0000836037,0.00049580395],"genre_scores_gemma":[0.52715296,0.46003985,0.0053610657,0.0018551596,0.000997402,0.0021711385,0.0017557006,0.000100156496,0.00056654325],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98241377,0.011062135,0.0032278015,0.0015726887,0.0012937984,0.0004298938],"domain_scores_gemma":[0.968702,0.024018282,0.004493068,0.0012425141,0.0011652397,0.00037880518],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.024050888,0.0030940836,0.020160362,0.0043691057,0.00049809174,0.0032704696,0.0019611062,0.0019817161,0.003926716],"category_scores_gemma":[0.036009878,0.0013485813,0.04999937,0.0051131207,0.0006555039,0.0016466225,0.0011789488,0.0025973655,0.00031965127],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01139208,0.0000423908,0.0037139992,0.060614273,0.9164058,0.00005734359,0.000024309024,0.0006458803,0.000110211935,0.00007392007,0.00036154405,0.0065583405],"study_design_scores_gemma":[0.0038103887,0.00035865154,0.003091056,0.0038545583,0.98761857,0.00004221001,0.000014989637,0.00033856687,0.00006480753,0.0002346004,0.00055530015,0.000016288379],"about_ca_topic_score_codex":0.0025670754,"about_ca_topic_score_gemma":0.004332039,"teacher_disagreement_score":0.9798396,"about_ca_system_score_codex":0.001700686,"about_ca_system_score_gemma":0.0018585471,"threshold_uncertainty_score":0.12719476},"labels":[],"label_agreement":null},{"id":"W4390816339","doi":"10.4081/cardio.2023.2","title":"SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials","year":2023,"lang":"en","type":"article","venue":"Global Cardiology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Empagliflozin; Dapagliflozin; Medicine; Hazard ratio; Internal medicine; Placebo; Randomized controlled trial; Relative risk; Meta-analysis; Diabetes mellitus; Confidence interval; Type 2 diabetes; Endocrinology","score_opus":0.044553951690806344,"score_gpt":0.33098623453234705,"score_spread":0.2864322828415407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390816339","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019606743,0.9756766,0.0018714728,0.0004596069,0.00045342735,0.0005493283,0.00080343144,0.0000836037,0.00049580395],"genre_scores_gemma":[0.52715296,0.46003985,0.0053610657,0.0018551596,0.000997402,0.0021711385,0.0017557006,0.000100156496,0.00056654325],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98241377,0.011062135,0.0032278015,0.0015726887,0.0012937984,0.0004298938],"domain_scores_gemma":[0.968702,0.024018282,0.004493068,0.0012425141,0.0011652397,0.00037880518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024050888,0.0030940836,0.020160362,0.0043691057,0.00049809174,0.0032704696,0.0019611062,0.0019817161,0.003926716],"category_scores_gemma":[0.036009878,0.0013485813,0.04999937,0.0051131207,0.0006555039,0.0016466225,0.0011789488,0.0025973655,0.00031965127],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01139208,0.0000423908,0.0037139992,0.060614273,0.9164058,0.00005734359,0.000024309024,0.0006458803,0.000110211935,0.00007392007,0.00036154405,0.0065583405],"study_design_scores_gemma":[0.0038103887,0.00035865154,0.003091056,0.0038545583,0.98761857,0.00004221001,0.000014989637,0.00033856687,0.00006480753,0.0002346004,0.00055530015,0.000016288379],"about_ca_topic_score_codex":0.0025670754,"about_ca_topic_score_gemma":0.004332039,"teacher_disagreement_score":0.024050888,"about_ca_system_score_codex":0.001700686,"about_ca_system_score_gemma":0.0018585471,"threshold_uncertainty_score":0.12719476},"labels":[],"label_agreement":null},{"id":"W4400213250","doi":"10.4081/cardio.2024.40","title":"Baseline echocardiographic characteristics of patients enrolled in the randomized investigation of MitraClip device in heart failure (RESHAPE HF-2) trial: comparison with COAPT and Mitra-FR","year":2024,"lang":"en","type":"article","venue":"Global Cardiology","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); Health Care Foundation","funders":"Abbott Vascular; St. Jude Medical; Daiichi Sankyo Europe; Servier; Innosuisse - Schweizerische Agentur für Innovationsförderung; Vifor Pharma; Universität Zürich; CytoSorbents Europe; Deutsche Forschungsgemeinschaft; British Heart Foundation; Sanofi; Abiomed; Horizon Therapeutics; Pfizer; Moderna; MicroPort; Impulse Dynamics; Hamilton Health Sciences; Mundipharma Medical Company, Basel; Kiniksa Pharmaceuticals; Cytokinetics; Biosense Webster; Novo Nordisk; HeartWare; ZOLL Medical Corporation; Regeneron Pharmaceuticals; Boston Scientific Corporation; AstraZeneca; Amarin Corporation; Javna Agencija za Raziskovalno Dejavnost RS; Alexion Pharmaceuticals; Thoratec Corporation; Cardinal Health; Edwards Lifesciences; Amgen; Eli Lilly and Company; Bayer Vital; Bristol-Myers Squibb","keywords":"Medicine; Ejection fraction; MitraClip; Internal medicine; Cardiology; Heart failure; Randomized controlled trial; Mitral regurgitation","score_opus":0.01189000808189308,"score_gpt":0.30609408339499217,"score_spread":0.2942040753130991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400213250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963167,0.001610517,0.00011399123,0.00015254352,0.00006644568,0.0003364398,0.0006163683,0.000006571632,0.00078055484],"genre_scores_gemma":[0.9963761,0.00038462065,0.0001768435,0.00032701826,0.00019098124,0.0006083053,0.0014251731,0.000003333107,0.0005075567],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9989454,0.0004960889,0.00009885866,0.00022815939,0.00009322806,0.00013829225],"domain_scores_gemma":[0.99878305,0.00036466602,0.00030197008,0.00009853501,0.00006589588,0.00038599438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020542333,0.0007465076,0.0016856494,0.0002732393,0.00029826086,0.0006946728,0.00044052102,0.0013234641,0.0032916262],"category_scores_gemma":[0.002127213,0.0003624748,0.0010802669,0.00027548178,0.00047308684,0.00076603325,0.00033521108,0.0010523044,0.00036033918],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89943254,0.0059460727,0.077147566,0.000389024,0.0019353345,0.0001030016,0.00007297119,0.00049610564,0.0027072465,0.00015633376,0.0010212443,0.010592665],"study_design_scores_gemma":[0.48347753,0.19547805,0.31089798,0.00014707947,0.0039029054,0.00027083448,0.00016143295,0.0021438147,0.0011723348,0.0004152884,0.0018538358,0.00007893264],"about_ca_topic_score_codex":0.00032259827,"about_ca_topic_score_gemma":0.00056120666,"teacher_disagreement_score":0.0032916262,"about_ca_system_score_codex":0.00026997906,"about_ca_system_score_gemma":0.00042951934,"threshold_uncertainty_score":0.0110116005},"labels":[],"label_agreement":null},{"id":"W4410048829","doi":"10.4081/cardio.2025.70","title":"iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025","year":2025,"lang":"en","type":"article","venue":"Global Cardiology","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital; Population Health Research Institute; University of Alberta; University of Manitoba","funders":"National Taiwan University Hospital; Universität des Saarlandes; National Taiwan University; Heart Research Institute; McMaster University; Vanderbilt University","keywords":"Context (archaeology); Alliance; Risk analysis (engineering); Health care; Medicine; Population; Resource (disambiguation); Heart failure; Intensive care medicine; Business; Computer science; Political science","score_opus":0.03200285949723429,"score_gpt":0.3950073607025411,"score_spread":0.3630045012053068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410048829","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013550505,0.091827594,0.026709197,0.48602164,0.043450452,0.0076661035,0.036127195,0.0027544044,0.30408838],"genre_scores_gemma":[0.013200175,0.116354644,0.14376935,0.45156172,0.017052442,0.028596368,0.08740769,0.0022626743,0.13979499],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96679795,0.012862989,0.007850156,0.0010151417,0.009337145,0.002136608],"domain_scores_gemma":[0.9427398,0.018502686,0.006153757,0.0017369757,0.027737403,0.003129362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03917267,0.0019660653,0.0024073666,0.0075908573,0.0017921304,0.00841124,0.006715377,0.017599056,0.028592478],"category_scores_gemma":[0.08665161,0.0013228403,0.00505548,0.0054597924,0.0024750507,0.0040437235,0.006471094,0.012033445,0.023222372],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000389064,0.0000693833,0.00042729487,0.0024363613,0.000039187325,0.00012448136,0.00025962412,0.00028457274,0.00012059373,0.012296298,0.89968854,0.084214605],"study_design_scores_gemma":[0.00010792953,0.00003682446,0.0013452482,0.013320792,0.000067493,0.00012640137,0.00015702727,0.00015205923,0.00009433166,0.004835519,0.97972006,0.000036229663],"about_ca_topic_score_codex":0.03551447,"about_ca_topic_score_gemma":0.034079205,"teacher_disagreement_score":0.03917267,"about_ca_system_score_codex":0.007210194,"about_ca_system_score_gemma":0.046962902,"threshold_uncertainty_score":0.20716733},"labels":[],"label_agreement":null},{"id":"W4412471224","doi":"10.4081/cardio.2025.77","title":"Applicability of obesity clinical practice guidelines in low- and middle-income countries","year":2025,"lang":"en","type":"article","venue":"Global Cardiology","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Obesity; Medicine; Specialty; Disease; Family medicine; Clinical Practice; Developing country; Environmental health; Gerontology; Pathology; Economic growth","score_opus":0.13656596509784596,"score_gpt":0.5270420251768815,"score_spread":0.3904760600790355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412471224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9014495,0.008143047,0.0012072363,0.060102943,0.00043335187,0.00071627955,0.0010055338,0.000067425026,0.026874669],"genre_scores_gemma":[0.9859759,0.0028019159,0.003706145,0.0063228947,0.000076294054,0.0002586704,0.00032782243,0.000016768452,0.0005135028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97593474,0.013799295,0.004258288,0.0011284439,0.003206612,0.0016726489],"domain_scores_gemma":[0.9029163,0.03814526,0.025472913,0.002385127,0.015445476,0.01563499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022485513,0.00014178535,0.00026194844,0.0014055382,0.0014342723,0.0024744952,0.00088973314,0.0011953964,0.002873353],"category_scores_gemma":[0.09192856,0.00037121217,0.00025794664,0.0021445255,0.0009982935,0.0017248951,0.0024698758,0.0015269483,0.00034603546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017217873,0.00040091318,0.80234826,0.0015346546,0.000062004205,0.001455694,0.043881714,0.00027652262,0.00069392327,0.0015174308,0.026107205,0.121549524],"study_design_scores_gemma":[0.00014712132,0.0005931336,0.820593,0.0063554468,0.000055660337,0.0016034552,0.10751792,0.0009807616,0.00038504764,0.0015429545,0.060111716,0.000113774724],"about_ca_topic_score_codex":0.01303696,"about_ca_topic_score_gemma":0.020512387,"teacher_disagreement_score":0.022485513,"about_ca_system_score_codex":0.002725352,"about_ca_system_score_gemma":0.010679173,"threshold_uncertainty_score":0.118916154},"labels":[],"label_agreement":null},{"id":"W4413893866","doi":"10.4081/cardio.2025.80","title":"Lipoprotein(a): what clinicians need to know","year":2025,"lang":"en","type":"article","venue":"Global Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Need to know; Medicine; Intensive care medicine; Computer science; Computer security","score_opus":0.011634917237357392,"score_gpt":0.3144226758901416,"score_spread":0.30278775865278423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413893866","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007607891,0.24808605,0.0023571362,0.69172025,0.042549215,0.00009972756,0.0004587415,0.00050164893,0.013466395],"genre_scores_gemma":[0.010055761,0.36840266,0.009359503,0.502306,0.0924605,0.0003863867,0.0011714787,0.00021119611,0.015646571],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99640733,0.0009650673,0.00054272043,0.00040321136,0.001349629,0.00033202232],"domain_scores_gemma":[0.9732421,0.007215703,0.0011021479,0.0010634498,0.011797857,0.005578666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043643336,0.0014921773,0.0031869793,0.0027705296,0.0018489856,0.005968649,0.0027632064,0.012295312,0.031302877],"category_scores_gemma":[0.036291055,0.0005767852,0.0014343795,0.0014191131,0.0026185166,0.01287679,0.0026401558,0.0144335665,0.02311297],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077824414,0.00011857451,0.0014443825,0.001487588,0.000033952376,0.0007212094,0.00020377818,0.000051846884,0.00012713487,0.0016509615,0.728959,0.26512387],"study_design_scores_gemma":[0.00008927756,0.00008019948,0.0023287688,0.013376221,0.00007612414,0.004766801,0.002266378,0.00016003233,0.00008770361,0.018337687,0.95832294,0.0001077124],"about_ca_topic_score_codex":0.0055672657,"about_ca_topic_score_gemma":0.0063267,"teacher_disagreement_score":0.031302877,"about_ca_system_score_codex":0.0022274707,"about_ca_system_score_gemma":0.0065947585,"threshold_uncertainty_score":0.10471851},"labels":[],"label_agreement":null},{"id":"W7084034459","doi":"10.4081/cardio.2025.86","title":"iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease","year":2025,"lang":"en","type":"article","venue":"Global Cardiology","topic":"Genetics, Bioinformatics, and Biomedical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Institut universitaire de cardiologie et de pneumologie de Québec; St. Boniface Hospital","funders":"","keywords":"Health care; Alliance; Global health; Resource (disambiguation); MEDLINE; Disease management; Burden of disease","score_opus":0.03768081832754278,"score_gpt":0.392106304695882,"score_spread":0.3544254863683392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7084034459","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021323722,0.09937932,0.043955177,0.50137794,0.038308248,0.0056950473,0.039251763,0.0043059704,0.26559412],"genre_scores_gemma":[0.018454453,0.16839814,0.20077914,0.38578162,0.015751848,0.021630336,0.07752316,0.0031451222,0.108536206],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97595584,0.00911484,0.004660402,0.0009661547,0.0074736546,0.0018291433],"domain_scores_gemma":[0.9489111,0.014337744,0.0054391376,0.0017824782,0.025265988,0.004263564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02822351,0.0018791505,0.0023261206,0.006356913,0.0016780683,0.0057417117,0.0060717124,0.01165958,0.02682324],"category_scores_gemma":[0.06564384,0.00095029885,0.00556531,0.0047119134,0.0019206683,0.0029600412,0.0063240505,0.0140144285,0.02167965],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007547453,0.00018339566,0.0012973057,0.00294422,0.00010497825,0.00016582661,0.00031828418,0.00037101022,0.00030000214,0.010976527,0.85183287,0.13143031],"study_design_scores_gemma":[0.00014304247,0.00005710679,0.0029844518,0.012743246,0.00015980842,0.00016444222,0.00018132654,0.00018400874,0.00016978568,0.004885101,0.9782768,0.000050913848],"about_ca_topic_score_codex":0.03923715,"about_ca_topic_score_gemma":0.03850539,"teacher_disagreement_score":0.03923715,"about_ca_system_score_codex":0.005879547,"about_ca_system_score_gemma":0.036789365,"threshold_uncertainty_score":0.14926201},"labels":[],"label_agreement":null}]}